The Egyptian Drug Authority has concluded a specialized training program entitled “From Molecule to Message: Scientific Integrity and Strategic Inspiration in Diabetes Promotion”, conducted in collaboration with a pharmaceutical company.

The program aimed to enhance comprehensive scientific understanding and support ethical practices in pharmaceutical promotion. It focused on linking scientific data with the latest clinical guidelines and the regulatory and promotional context, thereby supporting evidence-based decision-making and reinforcing compliance with established regulatory standards.

The program included a session on diabetes management according to the latest 2025 guidelines from the American Diabetes Association (ADA) and the International Diabetes Federation (IDF), with an emphasis on practical application within the Egyptian healthcare system. It also featured a session on medical decision-making by physicians, addressing the balance between efficacy, safety, and patient preferences, supported by practical case examples. Additionally, a marketing-focused session within the Authority’s regulatory framework covered how to develop promotional campaigns and educational materials (Detail Aids) based on sound scientific principles, ensuring both scientific accuracy and clarity of awareness messages in compliance with Egyptian Drug Authority standards.

The implementation of this program reflects the Authority’s ongoing efforts to advance regulatory practices and strengthen constructive communication between the regulatory body and pharmaceutical companies, positively impacting patient safety and the quality of healthcare in Egypt.